Tissue Solutions and Cambridge Blood and Stem Cell Biobank (CBSB) are partnering to speed up the turnaround of Covid-19 samples, as well as increase the usefulness of every sample donated to better support vaccine development.
The pair are hoping of bringing the turnaround time to 24 hours and divide each patient samples into multiple plasma or serum samples that can be sent out to various researchers.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Tissue Solutions CEO Morag McFarlane said: “We have responded quickly to the unique set of challenges brought about by this global pandemic.
“The scientific community urgently needs COVID-19 samples and we have adapted accordingly.
“The life sciences sector is undoubtably working more effectively together, which is helping us to achieve faster results.
“The demand for human tissue samples remains urgent across the UK and internationally.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCBSB lead scientist Dr Joanna Baxter added: “Our ethos is to make the most of each donation by processing different products from each sample, recognising the wishes of the participants to enable as much research as possible.”
